EMBC
Embecta Corp. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +5.9% ·
share flow -1.0% ·
net new positions +5.6%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 41.07K | $236,163 | n/a | n/a |
| Q2 2026 | 83 | -4 | 27.60M | $90.48M | +11 | −15 |
| Q1 2026 | 90 | -9 | 35.88M | $317.56M | +2 | −11 |
| Q4 2025 | 98 | +3 | 38.68M | $459.60M | +3 | n/a |
| Q3 2025 | 18 | +1 | 23.51M | $331.78M | +3 | −2 |
| Q2 2025 | 14 | +1 | 21.26M | $206.03M | +3 | −2 |
| Q1 2025 | 10 | -1 | 6.04M | $76.89M | n/a | −1 |
| Q4 2024 | 11 | -1 | 6.48M | $133.73M | n/a | −1 |
| Q3 2024 | 11 | +1 | 5.91M | $83.38M | +2 | −1 |
| Q2 2024 | 10 | n/a | 7.60M | $94.96M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 8.79M | -0.9% | $124.07M | 0.0% | ▼ Trim | 2 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (passive) | 5.46M | 0.0% | $77.10M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 2.33M | -2.9% | $32.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.44M | -21.3% | $20.27M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.43M | -5.6% | $20.15M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 904.41K | n/a | $12.76M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 7 | JPMorgan Chase ✦ | 869.64K | n/a | $12.27M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 8 | Goldman Sachs Group ✦ | 716.16K | n/a | $10.10M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | D. E. Shaw & Co. ✦ | 564.24K | -8.8% | $7.96M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | Arrowstreet Capital ✦ | 251.37K | New | $3.55M | 0.0% | New | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 221.20K | New | $3.12M | 0.0% | New | 1 | SEC ↗ ×3 |
| 12 | AQR Capital Management ✦ | 217.45K | +6.4% | $3.06M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 13 | Citadel Advisors ✦ | 86.30K | -15.3% | $1.22M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Gotham Asset Management ✦ | 75.01K | New | $1.06M | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 68.08K | +4.5% | $961,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 41.47K | -1.2% | $585,128 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Tweedy, Browne ✦ | 41.28K | +105.4% | $582,447 | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Fidelity (FMR) ✦ | 7.05K | +16.4% | $99,423 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $3.55M | 0.0% |
| Wellington Management | $3.12M | 0.0% |
| Gotham Asset Management | $1.06M | 0.0% |
Exited
| Point72 Asset Management | $741,285 | was 0.0% |
| Marshall Wace | $483,278 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 335 holders, 60.19M shares, $506.91M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer · SVP and CFO · 20.00K sh @ 4.67 · $93,360
Director · 45.00K sh @ 4.97 · $223,848
Officer · Pres, Pharm Svc&Prod… · 20.00K sh @ 4.99 · $99,800
Officer, Director · President and CEO · 30.00K sh @ 4.70 · $140,937
Open-market sales (S)
Director · 6.29K sh · $36,971
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology